- Posted October 21, 2013 by
- Investing In a Transformational Cannabis Businesses - MJNA
- Social Media – A Treasure Trove of Information for MJNA & CANV Investors
- Medical Marijuana Inc. – It’s All About the Marketing
- Medical Marijuana, Inc. is Active in Public Outreach to Help Kids
- Medical Marijuana, Inc Gains National Exposure on the Dr. Phil Show
Investors Respond to Medical Marijuana Inc’s Cibdex™ Product Release
I suspect the second wave of buying was due to some investors—who had not yet seen the press release--finding out for the first time that there might be a new catalyst for MJNA as they received notices in their cell phone and computer inboxes. It’s no secret that investors have been looking to the company to add products with more mass marketing appeal.
MJNA has been at the center of the evolution of the legitimate cannabis industry. They received significant notoriety as a leader in research and development while the push for various forms of legalization gained traction nationwide. While state-level legalization efforts have been encouraging and exciting, federal cannabis prohibition worried investors who were reluctant to put their faith in a “conglomerate” business model in an emerging and “high risk” industry.
Dr. Sanjay Gupta’s CNN documentary, WEED, boosted interest in cannabidiol (CBD), and investors wanted to see more focus on marketing this astonishingly promising substance. WEED highlighted CBD’s ability to treat a form of severe childhood epilepsy known as Dravet Syndrome, yet made no mention of CBD from hemp being legally available to parents and families nationwide.
Since February of this year, HempMedsPX has taken the lead as the exclusive master distributor and contracted marketing company for CannaVest Corp (CANV) and MJNA. HempMedsPX is a portfolio company of MJNA and markets products from other MJNA subsidiaries. The company hit the ground running by marketing and selling the consumer-ready products, and has been spending considerable time and effort to make consumers aware of future product rollouts.
Featured products now include CanChew™ hemp CBD gum, Real Scientific Hemp Oil™ (RSHO™), Cibdex™ and the Cibaderm™ product lines. So far the company has only introduced a CBD salve from the Cibaderm™ product line; however, the company is currently in the process of finalizing the formulations of its CBD Hemp Shampoo, Hemp Conditioner, Hemp Body Wash, Hemp Body Lotion and Hemp Hand Cream.
These are all premium products at a variety of price points for those looking for healthy and natural alternatives and for those that want to maximize the benefits of CBD. The introduction of these products marks a significant transformation for Medical Marijuana Inc. and CannaVest Corp. While Dr. Gupta’s acknowledgement that CBD offers significant medicinal benefits was a major revelation for many consumers, the company can’t make any medical claims and markets its offerings as dietary supplements or, in the case of Cibaderm™, personal care products.
However, those that have a need for the benefits of CBD will certainly not wait for the federal government to pass progressive legislation that would support wider research. CBD, when derived from industrial hemp, is actually legal to consume in all 50 of the United States, but growing hemp in the states and more research could be achieved when legislative hurdles are removed.
MJNA’s press release highlighted that HempMedsPX will be displaying products at the following tradeshows:
• CHAMPS Denver, CO Oct. 22-24 (Booth# 750)
• MMJ Business Daily Conference Seattle WA: Nov. 3-8
• San Francisco Green Festival San Francisco, CA: Nov. 9-10
• Michigan Medical Marijuana Trade Show: Nov. 15-17
Investors should take note as these product introductions and new product rollouts take place. As with any new product rollout, I would suspect that with the introduction of so many new products that HempMedsPX are working through their fair share of challenges. However, each product represents a new potential revenue stream. And with industry icon Cheryl Shuman coming on board as a “Brand Ambassador,” I would suspect that Friday’s price action was a sign of promising things to come.
Disclosure: I am an investor in MJNA and (OTC: CANV) and this article was written on behalf of Medical Marijuana, Inc.